相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives
Elsa P. Bianchini et al.
BLOOD (2011)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
A. Hillarp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis
Harry R. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
Tomas L. Lindahl et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
Manesh R. Patel
AMERICAN HEART JOURNAL (2010)
Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
Yu Chen Barrett et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin
Mark A. Crowther et al.
ANNALS OF INTERNAL MEDICINE (2009)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
John H. Alexander et al.
CIRCULATION (2009)
Emergency reversal of antithrombotic treatment
Marcel Levi
INTERNAL AND EMERGENCY MEDICINE (2009)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
J. L. Mega et al.
LANCET (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Alexander G. G. Turpie et al.
LANCET (2009)
Prasugrel in Clinical Practice.
Deepak L. Bhatt
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intravenous Platelet Blockade with Cangrelor during PCI.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Platelet Inhibition with Cangrelor in Patients Undergoing PCI.
Robert A. Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
Michael Rud Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
Harry R. Buller et al.
BLOOD (2008)
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based
Marcel Levi et al.
BLOOD (2008)
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
Mark A. Crowther et al.
BLOOD (2008)
Antithrombotic and thrombolytic therapy
Jack Hirsh et al.
CHEST (2008)
Hemorrhagic complications of anticoagulant and thrombolytic treatment
Sam Schulman et al.
CHEST (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Prevention of venous thromboembolism
William H. Geerts et al.
CHEST (2008)
Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal:: a prospective multinational clinical trial
I. Pabinger et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study
H. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Dabigatran etexilate
Bengt I. Eriksson et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
Michael R. Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement:: a randomised, double-blind, non-inferiority trial
Bengt I. Eriksson et al.
LANCET (2007)
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939) - The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study
Giancarlo Agnelli et al.
CIRCULATION (2007)
Drug therapy: Prevention and treatment of major blood loss
Pier Mannuccio Mannucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
Cindy L. Grines et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2007)
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial
P. H. A. Halkes et al.
LANCET NEUROLOGY (2007)
Normalization of platelet reactivity in clopidogrel-treated subjects
G. Vilahur et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study
Jesper Hallas et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
John W. Eikelboom et al.
CIRCULATION (2006)
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms
F. Dentali et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit
MB Rothberg et al.
ANNALS OF INTERNAL MEDICINE (2005)
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
M Battistella et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
NR Bijsterveld et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The efficacy and safety of perioperative antiplatelet therapy
JC Merritt et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2004)
Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic
AH Abdelhafiz et al.
CLINICAL THERAPEUTICS (2004)
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
MC Fang et al.
ANNALS OF INTERNAL MEDICINE (2004)
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves -: A meta-analysis
R Vink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation -: A prospective randomized controlled study
A Lubetsky et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers
NR Bijsterveld et al.
CIRCULATION (2002)
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy - A randomized, controlled trial
MA Crowther et al.
ANNALS OF INTERNAL MEDICINE (2002)
Treatment of symptomatic venous thromboembolism:: Improving outcomes
HR Büller
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Direct thrombin inhibitors in acute coronary syndromes - Present and future
JI Weitz et al.
CIRCULATION (2002)
Upper gastrointestinal bleeding among users of NSAIDS: a population-based cohort study in Denmark
L Mellemkjaer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice
SL Jackson et al.
INTERNAL MEDICINE JOURNAL (2001)
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
P Mismetti et al.
BRITISH JOURNAL OF SURGERY (2001)
分享论文
